DEINOVE Logo

DEINOVE

Develops compounds from rare bacteria for cosmetics and new antibiotics.

ALDEI | PA

Overview

Corporate Details

ISIN(s):
FR0010879056 (+1 more)
LEI:
969500BEJSRFER0F2K08
Country:
France
Address:
1682 RUE DE LA VALSIERE, 34790 GRABELS

Description

DEINOVE is a biotechnology company that discovers, develops, and produces high-value compounds derived from rare bacteria and microorganisms, often referred to as 'microbial dark matter'. Leveraging a proprietary technology platform, the company harnesses the metabolic potential of extremophilic bacteria, such as Deinococcus, to create innovative solutions. Its primary applications are focused on developing novel bio-based active ingredients, including carotenoids, for the cosmetics sector, and discovering new antibiotics to address the global challenge of antimicrobial resistance.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-01-24 17:45
Conversion de la procédure de redressement judiciaire en liquidation judiciaire
French 80.4 KB
2023-01-24 17:45
Conversion of the receivership proceedings into judicial liquidation proceedings
English 67.6 KB
2023-01-16 19:09
DEINOVE - Point sur la procédure de redressement judiciaire
French 79.4 KB
2023-01-16 19:09
DEINOVE - Update on the receivership proceedings
English 66.5 KB
2022-12-16 18:10
DEINOVE - Point sur la Procédure de Redressement Judiciaire
French 80.2 KB
2022-12-16 18:10
DEINOVE - Update on the Receivership Proceedings
English 67.5 KB
2022-11-07 17:45
Deinove annonce L’ouverture d’une procédure de redressement judiciaire
French 72.0 KB
2022-11-07 17:45
Deinove Announces the Opening of Receivership Proceedings
English 89.5 KB
2022-10-28 17:51
DEINOVE REQUESTS RECEIVERSHIP PROCEEDINGS
English 67.6 KB
2022-10-28 17:51
DEINOVE SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE
French 68.6 KB
2022-10-20 17:45
DEINOVE - Adoption of the resolutions at the Shareholders’ Extraordinary Genera…
English 69.8 KB
2022-10-20 17:45
DEINOVE - Adoption de l'ensemble des résolutions de son Assemblée Générale Extr…
French 71.2 KB
2022-10-10 17:45
DEINOVE - Extraordinary General Meeting of October 17, 2022: Appointment of an …
English 86.3 KB
2022-10-10 17:45
DEINOVE- Assemblée générale extraordinaire du 17 octobre 2022 : Désignation d'u…
French 88.2 KB
2022-10-06 19:02
DEINOVE présente ses résultats financiers et l’avancée de ses programmes pour l…
French 239.0 KB

Automate Your Workflow. Get a real-time feed of all DEINOVE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DEINOVE

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DEINOVE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.